{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T13:35:46Z","timestamp":1791207346805,"version":"4.1.0"},"reference-count":12,"publisher":"American Society of Hematology","issue":"18","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,9,23]]},"DOI":"10.1182\/bloodadvances.2025016665","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T16:07:09Z","timestamp":1751472429000},"page":"4580-4584","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":7,"title":["Asciminib for relapsed or refractory Philadelphia chromosome\u2013positive acute lymphoblastic leukemia"],"prefix":"10.1182","volume":"9","author":[{"given":"Mathilde","family":"Chanut","sequence":"first","affiliation":[{"name":"1Hematology Department, Centre Hospitalier de Versailles, Le Chesnay Rocquencourt, France"},{"name":"2Group for Research on Adult Acute Lymphoblastic Leukemia, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lie","family":"Cabannes-Hamy","sequence":"additional","affiliation":[{"name":"1Hematology Department, Centre Hospitalier de Versailles, Le Chesnay Rocquencourt, France"},{"name":"2Group for Research on Adult Acute Lymphoblastic Leukemia, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Balsat","sequence":"additional","affiliation":[{"name":"2Group for Research on Adult Acute Lymphoblastic Leukemia, Paris, France"},{"name":"3Hematology Department, Lyon University Hospital, Lyon, France"},{"name":"4French Intergroup for Chronic Myelogenous Leukemia, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1281-3802","authenticated-orcid":false,"given":"Nassim","family":"Sahki","sequence":"additional","affiliation":[{"name":"5Clinical Research Department, Centre Hospitalier de Versailles, Le Chesnay Rocquencourt, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Raffoux","sequence":"additional","affiliation":[{"name":"2Group for Research on Adult Acute Lymphoblastic Leukemia, Paris, France"},{"name":"6Adult Hematology Department, St-Louis Hospital, Assistance Publique\u2013H\u00f4pitaux de Paris, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosr","family":"Hicheri","sequence":"additional","affiliation":[{"name":"2Group for Research on Adult Acute Lymphoblastic Leukemia, Paris, France"},{"name":"7Department of Hematology, Institut Paoli-Calmettes, Marseille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Lioure","sequence":"additional","affiliation":[{"name":"2Group for Research on Adult Acute Lymphoblastic Leukemia, Paris, France"},{"name":"8Department of Onco-Hematology, University of Strasbourg, Institut de Canc\u00e9rologie Strasbourg Europe, Strasbourg, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucie","family":"Laemmel","sequence":"additional","affiliation":[{"name":"2Group for Research on Adult Acute Lymphoblastic Leukemia, Paris, France"},{"name":"9Hematology Department, Bordeaux University Hospital, Pessac, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3123-4948","authenticated-orcid":false,"given":"Thibaut","family":"Leguay","sequence":"additional","affiliation":[{"name":"2Group for Research on Adult Acute Lymphoblastic Leukemia, Paris, France"},{"name":"9Hematology Department, Bordeaux University Hospital, Pessac, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Cacheux","sequence":"additional","affiliation":[{"name":"2Group for Research on Adult Acute Lymphoblastic Leukemia, Paris, France"},{"name":"10Hematology Department, Clermont-Ferrand University Hospital, Clermont Ferrand, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Pilar","family":"Gallego-Hernanz","sequence":"additional","affiliation":[{"name":"2Group for Research on Adult Acute Lymphoblastic Leukemia, Paris, France"},{"name":"11Hematology Department, Poitiers University Hospital, Poitiers, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Pieragostini","sequence":"additional","affiliation":[{"name":"2Group for Research on Adult Acute Lymphoblastic Leukemia, Paris, France"},{"name":"12Hematology Department, Dijon University Hospital, Dijon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabrielle","family":"Roth-Guepin","sequence":"additional","affiliation":[{"name":"2Group for Research on Adult Acute Lymphoblastic Leukemia, Paris, France"},{"name":"13Hematology Department, Nancy University Hospital, Nancy, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludovic","family":"Gabellier","sequence":"additional","affiliation":[{"name":"2Group for Research on Adult Acute Lymphoblastic Leukemia, Paris, France"},{"name":"14Hematology Department, Montpellier University Hospital, Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Denizon","sequence":"additional","affiliation":[{"name":"2Group for Research on Adult Acute Lymphoblastic Leukemia, Paris, France"},{"name":"15Hematology Department, Le Mans Hospital, Le Mans, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lise","family":"Willems","sequence":"additional","affiliation":[{"name":"2Group for Research on Adult Acute Lymphoblastic Leukemia, Paris, France"},{"name":"16Hematology Department, Cochin Hospital, Assistance Publique\u2013H\u00f4pitaux de Paris, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quentin","family":"Cabrera","sequence":"additional","affiliation":[{"name":"2Group for Research on Adult Acute Lymphoblastic Leukemia, Paris, France"},{"name":"17Department of Onco-Hematology, La R\u00e9union University Hospital, Saint Pierre, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0457-2252","authenticated-orcid":false,"given":"Sylvain","family":"Chantepie","sequence":"additional","affiliation":[{"name":"2Group for Research on Adult Acute Lymphoblastic Leukemia, Paris, France"},{"name":"18Hematology Department, University Hospital, Caen, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0776-4615","authenticated-orcid":false,"given":"Val\u00e9rie","family":"Coiteux","sequence":"additional","affiliation":[{"name":"2Group for Research on Adult Acute Lymphoblastic Leukemia, Paris, France"},{"name":"4French Intergroup for Chronic Myelogenous Leukemia, Lyon, France"},{"name":"19Hematology Department, Lille University Hospital, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudie","family":"Capdupuy","sequence":"additional","affiliation":[{"name":"2Group for Research on Adult Acute Lymphoblastic Leukemia, Paris, France"},{"name":"20Hematology Department, C\u00f4te Basque Hospital Center, Bayonne, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Carr\u00e9","sequence":"additional","affiliation":[{"name":"2Group for Research on Adult Acute Lymphoblastic Leukemia, Paris, France"},{"name":"21Hematology Department, Grenoble University Hospital, Grenoble, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Machet","sequence":"additional","affiliation":[{"name":"2Group for Research on Adult Acute Lymphoblastic Leukemia, Paris, France"},{"name":"22Hematology Department, Tours University Hospital, Tours, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5142-0310","authenticated-orcid":false,"given":"Juliette","family":"Lambert","sequence":"additional","affiliation":[{"name":"1Hematology Department, Centre Hospitalier de Versailles, Le Chesnay Rocquencourt, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrine","family":"Roux","sequence":"additional","affiliation":[{"name":"5Clinical Research Department, Centre Hospitalier de Versailles, Le Chesnay Rocquencourt, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franck-Emmanuel","family":"Nicolini","sequence":"additional","affiliation":[{"name":"4French Intergroup for Chronic Myelogenous Leukemia, Lyon, France"},{"name":"23Hematology Department, Centre L\u00e9on Berard, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2091-7927","authenticated-orcid":false,"given":"Nicolas","family":"Boissel","sequence":"additional","affiliation":[{"name":"2Group for Research on Adult Acute Lymphoblastic Leukemia, Paris, France"},{"name":"24Adolescent and Young Adult Hematology Department, Saint-Louis Hospital, Assistance Publique\u2013H\u00f4pitaux de Paris, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7098-092X","authenticated-orcid":false,"given":"Emmanuelle","family":"Clappier","sequence":"additional","affiliation":[{"name":"2Group for Research on Adult Acute Lymphoblastic Leukemia, Paris, France"},{"name":"25Laboratory of Hematology, Saint-Louis Hospital, Assistance Publique\u2013H\u00f4pitaux de Paris, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9987-7237","authenticated-orcid":false,"given":"Rathana","family":"Kim","sequence":"additional","affiliation":[{"name":"2Group for Research on Adult Acute Lymphoblastic Leukemia, Paris, France"},{"name":"25Laboratory of Hematology, Saint-Louis Hospital, Assistance Publique\u2013H\u00f4pitaux de Paris, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3238-4494","authenticated-orcid":false,"given":"Philippe","family":"Rousselot","sequence":"additional","affiliation":[{"name":"1Hematology Department, Centre Hospitalier de Versailles, Le Chesnay Rocquencourt, France"},{"name":"2Group for Research on Adult Acute Lymphoblastic Leukemia, Paris, France"},{"name":"4French Intergroup for Chronic Myelogenous Leukemia, Lyon, France"},{"name":"26Unit\u00e9 de Formation et de Recherche Simone Veil, University Versailles Paris-Saclay, Montigny-le-Bretonneux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2025,9,10]]},"reference":[{"issue":"23","key":"2025092310365699400_bib1","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1182\/blood.2023023502","article-title":"Nilotinib with or without cytarabine for Philadelphia-positive acute lymphoblastic leukemia","volume":"143","author":"Chalandon","year":"2024","journal-title":"Blood"},{"issue":"15","key":"2025092310365699400_bib2","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1002\/cncr.33539","article-title":"Outcome of patients with chronic myeloid leukemia in lymphoid blastic phase and Philadelphia chromosome-positive acute lymphoblastic leukemia treated with hyper-CVAD and dasatinib","volume":"127","author":"Morita","year":"2021","journal-title":"Cancer"},{"issue":"21","key":"2025092310365699400_bib3","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1001\/jama.2024.4783","article-title":"Ponatinib vs imatinib in frontline Philadelphia chromosome\u2013positive acute lymphoblastic leukemia: a randomized clinical trial","volume":"331","author":"Jabbour","year":"2024","journal-title":"JAMA"},{"issue":"1","key":"2025092310365699400_bib4","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s11864-019-0603-z","article-title":"Treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia","volume":"20","author":"Abou Dalle","year":"2019","journal-title":"Curr Treat Options Oncol"},{"issue":"7647","key":"2025092310365699400_bib5","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/nature21702","article-title":"The allosteric inhibitor ABL001 enables dual targeting of BCR-ABL1","volume":"543","author":"Wylie","year":"2017","journal-title":"Nature"},{"issue":"19","key":"2025092310365699400_bib6","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1182\/blood.2024024657","article-title":"Asciminib monotherapy as frontline treatment of chronic-phase chronic myeloid leukemia: results from the ASCEND study","volume":"144","author":"Yeung","year":"2024","journal-title":"Blood"},{"issue":"10","key":"2025092310365699400_bib7","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1056\/NEJMoa2400858","article-title":"Asciminib in newly diagnosed chronic myeloid leukemia","volume":"391","author":"Hochhaus","year":"2024","journal-title":"N Engl J Med"},{"issue":"14","key":"2025092310365699400_bib8","doi-asserted-by":"crossref","first-page":"3558","DOI":"10.1080\/10428194.2021.1966787","article-title":"Asciminib and ponatinib combination in Philadelphia chromosome-positive acute lymphoblastic leukemia","volume":"62","author":"Zerbit","year":"2021","journal-title":"Leuk Lymphoma"},{"issue":"7","key":"2025092310365699400_bib9","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1038\/s41375-024-02278-8","article-title":"Asciminib monotherapy in patients with chronic-phase chronic myeloid leukemia with the T315I mutation after \u22651 prior tyrosine kinase inhibitor: 2-year follow-up results","volume":"38","author":"Cortes","year":"2024","journal-title":"Leukemia"},{"issue":"24","key":"2025092310365699400_bib10","doi-asserted-by":"crossref","first-page":"4944","DOI":"10.1182\/blood-2009-04-214221","article-title":"Dasatinib treatment of chronic-phase chronic myeloid leukemia: analysis of responses according to preexisting BCR-ABL mutations","volume":"114","author":"M\u00fcller","year":"2009","journal-title":"Blood"},{"issue":"4","key":"2025092310365699400_bib11","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.ccell.2019.08.004","article-title":"Combining the allosteric inhibitor asciminib with ponatinib suppresses emergence of and restores efficacy against highly resistant BCR-ABL1 mutants","volume":"36","author":"Eide","year":"2019","journal-title":"Cancer Cell"},{"issue":"11","key":"2025092310365699400_bib12","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1038\/s41375-024-02411-7","article-title":"Impact of BCR::ABL1 single nucleotide variants on asciminib efficacy","volume":"38","author":"Innes","year":"2024","journal-title":"Leukemia"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/9\/18\/4580\/2411495\/blooda_adv-2025-016665-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/9\/18\/4580\/2411495\/blooda_adv-2025-016665-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T14:37:03Z","timestamp":1758638223000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/9\/18\/4580\/546039\/Asciminib-for-relapsed-or-refractory-Philadelphia"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,10]]},"references-count":12,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2025,9,23]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2025016665","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,9,23]]},"published":{"date-parts":[[2025,9,10]]}}}